EP395 - EpiEndo Pharma
"EpiEndo commences LPS challenge trial for lead candidate EP395 https://t.co/an3EkRExZt" (@NewsFromBW) Aug 31, 2022 
https://twitter.com/NewsFromBW/status/1564931799108964352
 
Aug 31, 2022
 
 
c81e75f6-ea39-426c-b159-ffa59055a94b.jpg